Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction

To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BT...

Full description

Saved in:
Bibliographic Details
Published inMædica Vol. 19; no. 1; p. 182
Main Authors Rashaan, R, Arkoumanis, P T, Gakis, C, Lyssiotis, F A, Michalis, J, Anagnostopoulos, P, Stratakis, K
Format Journal Article
LanguageEnglish
Published Romania 01.03.2024
Online AccessGet full text

Cover

More Information
Summary:To evaluate subcutaneous Botulinum toxin type A (BTX-A) efficacy in alleviating severe allodynia in complex regional pain syndrome (CRPS) type II post-digit reconstruction. After surgical debridement and flap reconstruction for post-traumatic necrosis, a CRPS type II patient received subcutaneous BTX-A. Assessments tracked symptom changes and daily life improvements. There are various CRPS management modalities, including rehabilitation and pharmacology. The limited efficacy of conventional non-steroidal antiinflammatory drugs contrasts with promising subcutaneous BTX-A, offering rapid pain relief. Our case underscores the efficacy of subcutaneous BTX-A in CRPS type II, prompting further research and safe outpatient protocol development.
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1841-9038
2069-6116
DOI:10.26574/maedica.2024.19.1.182